In summary, this study suggests that although there is a marked inflammatory response after ischemic stroke, NLRP3-dependent inflammation is not involved in exacerbation of the injury and thus does not represent a therapeutic target for ischemic brain injury. Here, NLRP3 is linked to ischemic stroke.